The pharmaceuticals, medicinal chemicals, seasonally adjusted index in Belgium has reduced to 346.7, a decrease of 1.3 (-0.4%) from 2023 Q4.
Pharmaceuticals, medicinal chemicals, seasonally adjusted index in Belgium
No matching regions
Data availability:
Regions:
82
Date range: 2005 Q1 to 2024 Q1
Points:
5,455
Measure:
Index
Similar regions to Belgium
Pharmaceuticals, medicinal chemicals
Belgium Pharmaceuticals, medicinal chemicals between 2005 Q1 and 2024 Q1
| Period | Pharmaceuticals, medicinal chemicals | Change |
|---|---|---|
| 2024 Q1 | 346.7 | -1.3 |
| 2023 Q4 | 348.0 | +61.2 |
| 2023 Q3 | 286.8 | -25.3 |
| 2023 Q2 | 312.1 | -106.0 |
| 2023 Q1 | 418.1 | -105.5 |
| 2022 Q4 | 523.6 | +95.4 |
| 2022 Q3 | 428.2 | +48.2 |
| 2022 Q2 | 380.0 | -85.8 |
| 2022 Q1 | 465.8 | -5.3 |
| 2021 Q4 | 471.1 | -33.2 |
| 2021 Q3 | 504.3 | +23.6 |
| 2021 Q2 | 480.7 | +185.6 |
| 2021 Q1 | 295.1 | +65.3 |
| 2020 Q4 | 229.8 | +32.4 |
| 2020 Q3 | 197.4 | -28.1 |
| 2020 Q2 | 225.5 | +37.2 |
| 2020 Q1 | 188.3 | +2.2 |
| 2019 Q4 | 186.1 | -13.5 |
| 2019 Q3 | 199.6 | +3.5 |
| 2019 Q2 | 196.1 | +27.5 |
| 2019 Q1 | 168.6 | +16.7 |
| 2018 Q4 | 151.9 | -3.1 |
| 2018 Q3 | 155.0 | +20.2 |
| 2018 Q2 | 134.8 | +10.0 |
| 2018 Q1 | 124.8 | +17.5 |
| 2017 Q4 | 107.3 | -24.9 |
| 2017 Q3 | 132.2 | +18.4 |
| 2017 Q2 | 113.8 | -6.6 |
| 2017 Q1 | 120.4 | +0.9 |
| 2016 Q4 | 119.5 | -7.5 |
| 2016 Q3 | 127.0 | +13.6 |
| 2016 Q2 | 113.4 | +17.1 |
| 2016 Q1 | 96.3 | -4.4 |
| 2015 Q4 | 100.7 | -3.9 |
| 2015 Q3 | 104.6 | +6.5 |
| 2015 Q2 | 98.1 | +1.8 |
| 2015 Q1 | 96.3 | -20.6 |
| 2014 Q4 | 116.9 | +1.3 |
| 2014 Q3 | 115.6 | -18.4 |
| 2014 Q2 | 134.0 | +23.2 |
| 2014 Q1 | 110.8 | -2.6 |
| 2013 Q4 | 113.4 | +9.2 |
| 2013 Q3 | 104.2 | -6.6 |
| 2013 Q2 | 110.8 | +16.2 |
| 2013 Q1 | 94.6 | +1.3 |
| 2012 Q4 | 93.3 | -4.3 |
| 2012 Q3 | 97.6 | +19.7 |
| 2012 Q2 | 77.9 | -14.0 |
| 2012 Q1 | 91.9 | +10.9 |
| 2011 Q4 | 81.0 | -17.1 |
| 2011 Q3 | 98.1 | +5.3 |
| 2011 Q2 | 92.8 | -7.5 |
| 2011 Q1 | 100.3 | +13.2 |
| 2010 Q4 | 87.1 | +6.1 |
| 2010 Q3 | 81.0 | +1.8 |
| 2010 Q2 | 79.2 | -7.0 |
| 2010 Q1 | 86.2 | +15.7 |
| 2009 Q4 | 70.5 | +4.8 |
| 2009 Q3 | 65.7 | -1.3 |
| 2009 Q2 | 67.0 | +2.2 |
| 2009 Q1 | 64.8 | -7.4 |
| 2008 Q4 | 72.2 | +4.8 |
| 2008 Q3 | 67.4 | +3.5 |
| 2008 Q2 | 63.9 | -0.9 |
| 2008 Q1 | 64.8 | +4.4 |
| 2007 Q4 | 60.4 | -3.1 |
| 2007 Q3 | 63.5 | +1.3 |
| 2007 Q2 | 62.2 | +4.8 |
| 2007 Q1 | 57.4 | -10.0 |
| 2006 Q4 | 67.4 | +7.0 |
| 2006 Q3 | 60.4 | -0.9 |
| 2006 Q2 | 61.3 | -2.6 |
| 2006 Q1 | 63.9 | +3.5 |
| 2005 Q4 | 60.4 | +1.3 |
| 2005 Q3 | 59.1 | +1.7 |
| 2005 Q2 | 57.4 | 0.0 |
| 2005 Q1 | 57.4 |